Who invested in Pro-Cure Therapeutics?
Pro-Cure Therapeutics's investors include Yorkshire Cancer Research, Maven Capital Partners, YFM Venture Finance and White Rose Technology Seedcorn Fund.
United Kingdom · Venture startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$2.2Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by pro-cure.uk.com
Reported by pro-cure.uk.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Pro-Cure Therapeutics's investors include Yorkshire Cancer Research, Maven Capital Partners, YFM Venture Finance and White Rose Technology Seedcorn Fund.
Pro-Cure Therapeutics has raised $2.2M across 2 rounds since 2007.
Pro-Cure Therapeutics's most recent round was a Venture of $1.1M in Apr 2010.
Pro-Cure Therapeutics's largest round on record is $1.2M (Venture), in Nov 2007.
Pro-Cure Therapeutics's first round on record, in Nov 2007, was backed by White Rose Technology Seedcorn Fund and Yorkshire Cancer Research.
Pro-Cure Therapeutics's latest named round is a Venture, in Apr 2010.
Pro-Cure Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.